Who is Metabolic & Weight for?

It is built for patients who want meaningful fat loss without losing performance; anyone with insulin resistance or metabolic syndrome markers; people who have plateaued on diet and training alone; patients coming off GLP-1s who want to hold the result.

Metabolic and insulin-resistance biomarker panel; GLP-1 or dual-agonist therapy titrated by a physician; Muscle-preservation strategy: protein, training and adjunct support; Body composition tracking, not just scale weight; Off-ramp planning so results hold after the medication. Everything is delivered virtually — the only in-person step is your blood draw at a Quest patient service center.

What changes if the protocol is working?

Sustained fat loss with lean mass protected; Improved insulin sensitivity and lipid profile; Reduced inflammation and better energy; A maintenance plan you can actually run. Progress is measured against your own baseline labs at follow-up, not against an average.

How do I start, and what does it cost up front?

A $100 application fee reserves your intake and is credited in full toward your baseline labs. From there it is a Quest draw, a video visit with your clinician, a written protocol, and ongoing monitoring with follow-up panels.

← All Programs

Program 03

Prescription · Requires Consultation

Metabolic & Weight

Written by the Elevate Clinical Team

Citations independently verified against PubMed, ClinicalTrials.gov, and FDA sources on August 19, 2026. Independent clinical review pending.

Lose fat. Keep the engine.

GLP-1 medications work — and used without a plan they take muscle, strength and metabolic rate with the fat. Our metabolic protocols pair medication with protein targets, resistance training guidance and, where indicated, muscle-sparing peptides, so what you lose is the thing you meant to lose.

Who it's for

Patients who want meaningful fat loss without losing performance
Anyone with insulin resistance or metabolic syndrome markers
People who have plateaued on diet and training alone
Patients coming off GLP-1s who want to hold the result

What's included

Metabolic and insulin-resistance biomarker panel
GLP-1 or dual-agonist therapy titrated by a physician
Muscle-preservation strategy: protein, training and adjunct support
Body composition tracking, not just scale weight
Off-ramp planning so results hold after the medication

What changes

Sustained fat loss with lean mass protected
Improved insulin sensitivity and lipid profile
Reduced inflammation and better energy
A maintenance plan you can actually run

Begin Your Intake

Educational reference

The science behind the conversation.

The names below describe areas of clinical and scientific interest and do not guarantee availability. Elevate Chicago separates physician-supervised treatment from research-use products. A physician determines what, if anything, is appropriate for care after reviewing your history, goals and labs.

Important sourcing & research notice

Hormone therapy is prescription care. Every hormone we prescribe is dispensed through an appropriately licensed compounding pharmacy, and we use FDA-approved medications for their approved indications when applicable. FDA-registered 503B outsourcing facilities may be used when applicable. Pharmacy status, formulations and availability can change as federal and state requirements change.

When a suitable prescription formulation is not legally available through a compounding pharmacy, certain compounds may be offered separately by Elevate Chicago strictly for lawful laboratory or research use. These products are not FDA-approved medications, are not prescribed or dispensed as medical care, and are not intended for human or animal consumption or for the diagnosis, treatment, cure or prevention of disease. Buyers are responsible for using them only for lawful research and for complying with all applicable requirements. Nothing on this page is medical advice or a substitute for a physician evaluation.

COMPOUNDED — NOT FDA-APPROVED

Single Regulator (GLP-1) — semaglutide

Semaglutide, listed as Single Regulator (GLP-1) because compounded formulations cannot be marketed under the drug's commercial name. A GLP-1 medication containing an active ingredient also found in FDA-approved products; compounded formulations are not themselves FDA-approved.

COMPOUNDED — NOT FDA-APPROVED

Dual Regulator (GLP-1/GIP) — tirzepatide

Tirzepatide, listed as Dual Regulator (GLP-1/GIP) because compounded formulations cannot be marketed under the drug's commercial name. A GIP/GLP-1 medication containing an active ingredient also found in FDA-approved products; compounded formulations are not themselves FDA-approved.

NOT FDA-APPROVED

Triple Regulator (GLP-1/GIP/glucagon)

Triple agonist (GLP-1/GIP/glucagon) in clinical research

Read the one-pager FDA-APPROVED

Tesamorelin

Research into visceral adipose tissue signaling

Read the one-pager NOT FDA-APPROVED

AOD-9604

Investigational fat-oxidation research

Read the one-pager NOT FDA-APPROVED

MOTS-c

Investigational mitochondrial and insulin-sensitivity research

Read the one-pager COMPOUNDED — NOT FDA-APPROVED

CJC-1295 + Ipamorelin

Investigational lean-mass and recovery research

Read the one-pager

Open the full peptide library

Frequently asked questions.

What is the Metabolic & Weight program?: GLP-1 medications work — and used without a plan they take muscle, strength and metabolic rate with the fat. Our metabolic protocols pair medication with protein targets, resistance training guidance and, where indicated, muscle-sparing peptides, so what you lose is the thing you meant to lose.
Who is Metabolic & Weight for?: It is built for patients who want meaningful fat loss without losing performance; anyone with insulin resistance or metabolic syndrome markers; people who have plateaued on diet and training alone; patients coming off GLP-1s who want to hold the result.
What is included?: Metabolic and insulin-resistance biomarker panel; GLP-1 or dual-agonist therapy titrated by a physician; Muscle-preservation strategy: protein, training and adjunct support; Body composition tracking, not just scale weight; Off-ramp planning so results hold after the medication. Everything is delivered virtually — the only in-person step is your blood draw at a Quest patient service center.
What changes if the protocol is working?: Sustained fat loss with lean mass protected; Improved insulin sensitivity and lipid profile; Reduced inflammation and better energy; A maintenance plan you can actually run. Progress is measured against your own baseline labs at follow-up, not against an average.
How do I start, and what does it cost up front?: A $100 application fee reserves your intake and is credited in full toward your baseline labs. From there it is a Quest draw, a video visit with your clinician, a written protocol, and ongoing monitoring with follow-up panels.

Sources

1.Testosterone therapy in men with hypogonadism — clinical practice guideline— Endocrine Society
2.Compounding and the FDA: questions and answers— U.S. Food & Drug Administration
3.Test directory and patient service center locator— Quest Diagnostics
4.Telehealth policy and licensure requirements— U.S. Department of Health and Human Services

About this page

Written by the Elevate Clinical Team

Citations independently verified against PubMed, ClinicalTrials.gov, and FDA sources on August 19, 2026. Independent clinical review pending. Educational content only — not medical advice, not a diagnosis, and not an offer to sell any prescription product.

Explore

Other programs.

01Prescription · Requires Consultation